Is there sufficient evidence to include Cerebrolysin^® into treatment algorithms in AIS?

This webinar aimed to evaluate the current scientific and clincial data supporting the role of Cerebrolysin® in the treatment of acute ischemic stroke (AIS).

Two experts presented evidence-based perspectives:

• Prof. Michalak (Poland) presented his groundbreaking TAKE 5 project, outlines five key steps aimed at preserving the penumbra in acute stroke management.
  
• Prof. Krespi (Türkiye) shared findings from an investigator-initiated retrospective study, along with his institution’s treatment algorithm, which recommends the use of Cerebrolysin® for a broad spectrum of stroke patients.

Please find all details in the report below.

The full recording of the event you can find here.